- Home
- PET vs NXPLW Comparison
PET vs NXPLW Comparison
Compare PET & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PET
- NXPLW
- Stock Information
- Founded
- PET 2015
- NXPLW N/A
- Country
- PET United States
- NXPLW United States
- Employees
- PET N/A
- NXPLW 166
- Industry
- PET EDP Services
- NXPLW Telecommunications Equipment
- Sector
- PET Technology
- NXPLW Telecommunications
- Exchange
- PET Nasdaq
- NXPLW Nasdaq
- Market Cap
- PET N/A
- NXPLW N/A
- IPO Year
- PET N/A
- NXPLW N/A
- Fundamental
- Price
- PET $0.13
- NXPLW $0.16
- Analyst Decision
- PET Strong Buy
- NXPLW
- Analyst Count
- PET 5
- NXPLW 0
- Target Price
- PET $4.90
- NXPLW N/A
- AVG Volume (30 Days)
- PET 10.4M
- NXPLW 6.4K
- Earning Date
- PET 05-08-2025
- NXPLW 03-31-2025
- Dividend Yield
- PET N/A
- NXPLW N/A
- EPS Growth
- PET N/A
- NXPLW N/A
- EPS
- PET N/A
- NXPLW N/A
- Revenue
- PET $70,507,000.00
- NXPLW $66,482,000.00
- Revenue This Year
- PET $7.87
- NXPLW N/A
- Revenue Next Year
- PET $122.23
- NXPLW N/A
- P/E Ratio
- PET N/A
- NXPLW N/A
- Revenue Growth
- PET N/A
- NXPLW 179.89
- 52 Week Low
- PET $0.08
- NXPLW $0.25
- 52 Week High
- PET $2.47
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- PET 44.19
- NXPLW N/A
- Support Level
- PET $0.08
- NXPLW N/A
- Resistance Level
- PET $0.19
- NXPLW N/A
- Average True Range (ATR)
- PET 0.02
- NXPLW 0.00
- MACD
- PET 0.01
- NXPLW 0.00
- Stochastic Oscillator
- PET 48.67
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.